FCA Whistleblowers Accuse Gilead Of Defective-Drug Fraud

By Jeff Overley · September 11, 2014, 3:06 PM EDT

Gilead Sciences Inc. cheated taxpayers by selling contaminated and defective drugs to Medicare and Medicaid, whistleblowers charged in a False Claims Act lawsuit unsealed Wednesday in California federal court, adding to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login